Drug recall · August 6, 2025
Amlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mg recall
Why: Labeling: Incorrect or Missing Lot and/or Exp Date: released with wrong expiry date as Feb.2027 instead of Jan.2027
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Amlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mg, 100 Capsules bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL, 34108, United States, Manufactured by: Lupin Limited, Goa 103 722, INDIA, NDC 68180-755-01.
- Lots / codes
Lot GB01616, expiration 2/28/2027
- Quantity
- 7668 bottles
- Company
- Lupin Pharmaceuticals Inc., Naples, FL
- Distribution
- Nationwide in the US
- Initiated
- July 2, 2025 · Voluntary: Firm initiated
- Classified
- July 28, 2025
- Reported
- August 6, 2025
- Ended
- July 30, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amlodipine / benazepril
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.